Asim Farooq is an Ophthalmology physician affiliated with University of Chicago. OpenAlex indexes 73 publications with 755 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5841 S Maryland Ave
Chicago, IL 606371443
Telephone
888-824-0200Registry record last updated 24 Oct 2022.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202514 payments$38,214openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20256 payments$19,065openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
69.6%Corticosteroid28.9%Prednisolone Acetate81%Fluorometholone19%Part D≥135 patientsProstaglandin Analog13.3%Latanoprost90%Lumigan10%Part D<11 patients+ 4 more classes in this area
Anti-infectives
19.6%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor8.9%Valacyclovir100%Part D≥27 patientsTetracycline-class Drug6.7%Doxycycline Hyclate100%Part D≥26 patients+ 2 more classes in this area
Musculoskeletal
7%Cyclooxygenase Inhibitor7%Ketorolac Tromethamine100%Part D≥53 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Practical Guidance on Clinical Management of Belantamab Mafodotin‐Associated Ocular Events
American Journal of Hematology
2025 - Incorporating information retrieval into AI chatbots for patient education on thyroid eye disease
International Journal of Medical Informatics
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Everett Vokes, MD
University of Chicago
Ralph Weichselbaum, MD
University of Chicago
Mary Rinella, MD
University of Chicago
Hedy Kindler, MD
University of Chicago
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”